DAL MONTE, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 8.604
EU - Europa 3.874
AS - Asia 2.056
AF - Africa 253
SA - Sud America 24
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 14.825
Nazione #
US - Stati Uniti d'America 8.379
IT - Italia 1.662
CN - Cina 1.173
SE - Svezia 646
BG - Bulgaria 378
SG - Singapore 348
DE - Germania 246
CA - Canada 216
UA - Ucraina 194
TR - Turchia 158
GB - Regno Unito 153
FI - Finlandia 146
VN - Vietnam 134
CI - Costa d'Avorio 125
AT - Austria 85
RU - Federazione Russa 81
IN - India 71
CH - Svizzera 62
FR - Francia 62
HK - Hong Kong 61
NG - Nigeria 60
BE - Belgio 40
EG - Egitto 31
ID - Indonesia 30
NL - Olanda 24
SN - Senegal 21
BR - Brasile 19
CZ - Repubblica Ceca 17
JP - Giappone 17
AL - Albania 12
PL - Polonia 12
SA - Arabia Saudita 11
HU - Ungheria 10
ES - Italia 9
KE - Kenya 9
AU - Australia 8
IL - Israele 8
PH - Filippine 8
DK - Danimarca 7
KR - Corea 7
MX - Messico 7
BD - Bangladesh 6
GR - Grecia 6
IE - Irlanda 6
PK - Pakistan 5
EU - Europa 4
AE - Emirati Arabi Uniti 3
BJ - Benin 3
LT - Lituania 3
MU - Mauritius 3
NP - Nepal 3
PT - Portogallo 3
ME - Montenegro 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
RO - Romania 2
SI - Slovenia 2
TH - Thailandia 2
TW - Taiwan 2
AM - Armenia 1
AR - Argentina 1
BS - Bahamas 1
CL - Cile 1
EE - Estonia 1
IQ - Iraq 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
TN - Tunisia 1
VE - Venezuela 1
Totale 14.825
Città #
Fairfield 947
Woodbridge 860
Chandler 705
Santa Clara 684
Houston 622
Ashburn 528
Ann Arbor 515
Seattle 380
Sofia 378
Shanghai 359
Milan 354
Serra 336
Wilmington 321
Cambridge 317
Beijing 256
New York 247
Singapore 210
Ottawa 203
Boardman 189
Jacksonville 181
Princeton 178
Lawrence 146
Medford 132
Abidjan 125
Des Moines 115
Nanjing 109
Izmir 86
Vienna 76
Florence 61
Hong Kong 61
Istanbul 61
Bern 59
Lagos 57
San Diego 57
Los Angeles 55
Dong Ket 54
Falls Church 49
Dearborn 47
Nanchang 45
Munich 44
London 41
Pisa 39
Boulder 37
Brussels 37
Rome 36
Kunming 34
Redwood City 34
Jüchen 33
Chicago 32
Frankfurt am Main 32
Marseille 28
Helsinki 27
Washington 23
Hefei 22
Livorno 22
Shenyang 22
Dakar 21
Changsha 20
Ogden 20
Alessandria 19
Dallas 19
Norwalk 19
Napoli 18
Catania 17
Hebei 17
Fuzhou 16
Pune 16
Brno 15
Hangzhou 15
Lancaster 15
Bari 14
Quanzhou 14
Guangzhou 13
Mumbai 13
Tianjin 13
Auburn Hills 12
Cairo 12
Jiaxing 12
Lappeenranta 10
Viareggio 10
Xiamen 10
Jeddah 9
Jinan 9
Jakarta 8
Lucca 8
Scuola 8
Al Mansurah 7
Bremen 7
Massa 7
Surabaya 7
Capannori 6
Changchun 6
Empoli 6
Indiana 6
Many 6
Chengdu 5
Dhaka 5
Grafing 5
Kilburn 5
Modena 5
Totale 11.213
Nome #
Dexamethasone Improves Ofloxacin Efficacy in Treating Acute Bacterial Conjunctivitis: Evidence from A Rabbit Model 325
Exposure to extreme climatic environments reduces circulating endothelial progenitor cells. 202
Nanoparticle-Mediated Delivery of Neuroprotective Substances for the Treatment of Diabetic Retinopathy 188
Autophagy-mediated neuroprotection induced by octreotide in an ex vivo model of early diabetic retinopathy 186
Association between polymorphisms of TAS2R16 and susceptibility to colorectal cancer 169
Diabetic retinopathy: Neuroprotection as a therapeutic target 161
Agonisti selettivi dei recettori beta-adrenergici di tipo 3 (BAR3) e loro impiego 154
VEGF as a survival factor in ex vivo models of early diabetic retinopathy 146
S-thiolation mechanisms of aldose reductase 145
A new approach against sugar cataract through aldose reductase inhibitors 144
Lisosan G Protects the Retina from Neurovascular Damage in Experimental Diabetic Retinopathy 144
Altered morphology of rod bipolar cell axonal terminals in the retinas of mice carrying genetic deletion of somatostatin subtype receptor 1 or 2 143
In vitro and in vivo inhibition of proangiogenic retinal phenotype by an antisense oligonucleotide downregulating uPAR expression 141
Potential role of the methylation of VEGF gene promoter in response to hypoxia in oxygen-induced retinopathy: beneficial effect of the absence of AQP4 139
Somatostatin (SRIF) and SRIF receptors in the mouse retina 136
Zofenoprilat-Glutathione mixed disulfide as a specific S-thiolating agent of bovine lens aldose reductase 128
Antiangiogenic role of miR-361 in human umbilical vein endothelial cells: functional interaction with the peptide somatostatin 127
Role of host β1- and β2-adrenergic receptors in a murine model of B16 melanoma: functional involvement of β3-adrenergic receptors 127
The Urokinase Receptor-Derived Peptide UPARANT Recovers Dysfunctional Electroretinogram and Blood–Retinal Barrier Leakage in a Rat Model of Diabetes 127
Beta-adrenoreceptor agonism influences retinal responses to hypoxia in a model of retinopathy of prematurity 127
Prooxidative action of cysteine in the glutathione-mediated oxidative modification of lens aldose reductase 125
β3 adrenergic receptor in the kidney may be a new player in sympathetic regulation of renal function 125
The Urokinase Receptor-Derived Peptide UPARANT Mitigates Angiogenesis in a Mouse Model of Laser-Induced Choroidal Neovascularization 123
Modulation of aldose reductase activity through S-thiolation by physiological thiols 122
Efficacy of fatty acids dietary supplement in polyethylene glycol-induced mouse model of retinal degeneration 121
Beta3-adrenergic receptors modulate vascular endothelial growth factor release in response to hypoxia through the nitric oxide pathway in mouse retinal explants 119
Adenylyl cyclase/cAMP system involvement in the antiangiogenic effect of somatostatin in the retina. Results from transgenic mice 119
Lens glutathione S-transferase as a catalyst of transthiolation processes 118
Neurokinin 1 receptor expression and substance P physiological actions are developmentally regulated in the rabbit retina 118
Glio-vascular modifications caused by Aquaporin-4 deletion in the mouse retina 117
Involvement of cysteine residues in glutathione dependent modification of human aldose reductase 116
Specifically targeted modification of human aldose reductase by physiological disulfides 116
Expression, localization, and functional coupling of the somatostatin receptor subtype 2 in a mouse model of oxygen-induced retinopathy 116
The β-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseases 116
Coenzyme Q10 instilled as eye drops on the cornea reaches the retina and protects retinal layers from apoptosis in a mouse model of kainate-induced retinal damage 115
Acetyl-11-keto--boswellic acid reduces retinal angiogenesis in a mouse model of oxygen-induced retinopathy 115
Vascular Endothelial Growth Factor in the Ischemic Retina and Its Regulation by Somatostatin 114
The Beta Adrenergic Receptor Blocker Propranolol Counteracts Retinal Dysfunction in a Mouse Model of Oxygen Induced Retinopathy: Restoring the Balance Between Apoptosis and Autophagy 114
Antiangiogenic role of somatostatin receptor 2 in a model of hypoxia-induced neovascularization in the retina: results from transgenic mice 113
Alpha-crystallin acting as a molecular chaperone in preventing thermal induced denaturation of bovine lens sorbitol dehydrogenase 112
Diabetic Retinopathy in the Spontaneously Diabetic Torii Rat: Pathogenetic Mechanisms and Preventive Efficacy of Inhibiting the Urokinase-Type Plasminogen Activator Receptor System 112
Protective role of somatostatin receptor 2 against retinal degeneration in response to hypoxia 111
Indirect blockade of vascular endothelial growth factor: the potential for eye disease therapy 111
Thiol/disulfide interconversion in bovine lens aldose reductase induced by intermediates of glutathione turnover 111
Fatty Acids Dietary Supplements Exert Anti-Inflammatory Action and Limit Ganglion Cell Degeneration in the Retina of the EAE Mouse Model of Multiple Sclerosis 111
Purification and characterization of two odorant binding proteins from nasal tissue of rabbit and pig 110
Association of the Somatostatin Analog Octreotide With Magnetic Nanoparticles for Intraocular Delivery: A Possible Approach for the Treatment of Diabetic Retinopathy 110
Hypoxia effects on proangiogenic factors in human umbilical vein endothelial cells: functional role of the peptide somatostatin. 109
The pathophisiology of retinopathy of prematurity: an update of previous and recent knowledge 109
Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trial. 109
Somatostatin coupling to adenylyl cyclase activity in the mouse retina 109
Oral Propranolol for Retinopathy of Prematurity: Risks, Safety Concerns, and Perspectives 108
A nature‐inspired nrf2 activator protects retinal explants from oxidative stress and neurodegeneration 108
Inhibiting the urokinase-type plasminogen activator receptor system recovers STZ-induced diabetic nephropathy. 108
Coenzyme Q10 protects retinal cells from apoptosis induced by radiation in vitro and in vivo 106
Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial 104
β3-Adrenoreceptors Control Mitochondrial Dormancy in Melanoma and Embryonic Stem Cells 104
The urokinase-type plasminogen activator system as drug target in retinitis pigmentosa: New pre-clinical evidence in the rd10 mouse model 104
GLUTATHIONE-MODIFIED ALDOSE REDUCTASE IN OXIDATIVELY STRESSED BOVINE LENS 103
Effects of Somatostatin Analogues on Retinal Angiogenesis in a Mouse Model of Oxygen-Induced Retinopathy: Involvement of the Somatostatin Receptor Subtype 2 103
SITE-SPECIFIC OXIDATION OF BOVINE LENS ALDOSE REDUCTASE INDUCED BY COPPER-ION 102
Reversibility of S-thiolation of aldose reductase in intact bovine lens undergoing oxidative stress 102
Functional correlates of somatostatin receptor 2 over-expression in the retina of mice with genetic deletion of somatostatin receptor 1 101
Expression of Substance P, Neurokinin 1 receptors (NK1)and Neurokinin 3 receptors in the developing mouse retina and in the retina of NK1 knock out mice 101
Novel Insights into Beta 2 Adrenergic Receptor Function in the rd10 Model of Retinitis Pigmentosa 101
Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP) 101
Somatostatin receptors differentially affect spontaneous epileptiform activity in mouse hippocampal slices 100
β3 adrenergic receptor activity modulates melanoma cell proliferation and survival through nitric oxide signaling. 100
Chaperone-like activity of alpha-crystallin against thermal denaturation of sorbitol dehydrogenase 99
S-Thiolation of enzymes as a defence mechanism against oxidative stress 99
Identification of BRAF 3'UTR Isoforms in Melanoma. 99
Activation of the Thiazide-Sensitive Sodium-Chloride Cotransporter by Beta3-Adrenoreceptor in the Distal Convoluted Tubule. 99
Mechanisms underlying somatostatin receptor 2 downregulation of vascular endothelial growth factor expression in response to hypoxia in mouse retinal explants 98
Localization patterns of fibroblast growth factor 1 and its receptors FGFR1 and FGFR2 in postnatal mouse retina 97
Anti-angiogenic effectiveness of the urokinase receptor-derived peptide UPARANT in a model of oxygen induced retinopathy 97
Compensatory changes in the hippocampus of somatostatin knockout mice: upregulation of somatostatin receptor 2 and its function in the control of bursting activity and synaptic transmission 97
Further Evidence on Efficacy of Diet Supplementation with Fatty Acids in Ocular Pathologies: Insights from the EAE Model of Optic Neuritis. 95
A Dietary Combination of Forskolin with Homotaurine, Spearmint and B Vitamins Protects Injured Retinal Ganglion Cells in a Rodent Model of Hypertensive Glaucoma 94
High molecular weight hepatotrophic-scatter factors released in serum-free medium by the coltured embryo rat fibroblastic cell line FRL 93
Therapeutic Potential of Anti-Angiogenic Multi-Target N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy. 91
Signalling potential and protein modifying ability of physiological thiols 90
Functional involvement of β3-adrenergic receptors in melanoma growth and vascularization 89
Site-specific inactivation of aldose reductase by 4-hydroxynonenal. 88
BINDING OF SELECTED ODORANTS TO BOVINE AND PORCINE ODORANT-BINDING PROTEINS 88
UPARANT is an effective antiangiogenic agent in a mouse model of rubeosis iridis 88
Solid phase enzyme immunoassay for the Odorant Binding Protein (OBP) 87
Interconversion pathways of aldose reductase induced by thiol compounds 86
Interconversion pathways of aldose reductase induced by thiol compounds 86
Propranolol concentrations after oral administration in term and preterm neonates 86
Cysteinylglycine hydrolase activity in bovine lens 85
Involvement of the cAMP-dependent pathway in the reduction of epileptiform bursting caused by somatostatin in the mouse hippocampus 85
Thioltransferase activity of bovine lens glutathione S-transferase. 85
β3 -Adrenoceptor as a potential immuno-suppressor agent in melanoma. 83
Inactivation of bovine lens aldose reductase by 4-hydroxynonenal 81
Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the beta-adrenergic system 81
Oxidative Stress Induces a VEGF Autocrine Loop in the Retina: Relevance for Diabetic Retinopathy 80
Autophagy Involvement in the Postnatal Development of the Rat Retina 79
Antiangiogenic Effects of Beta2-Adrenergic Receptor Blockade in a Mouse Model of Oxygen-Induced Retinopathy 78
Propranolol 0.2% Eye Micro-Drops for Retinopathy of Prematurity: A Prospective Phase IIB Study 78
Protective effects of beta1/2 adrenergic receptor deletion in a model of oxygen induced retinopathy 77
Totale 11.319
Categoria #
all - tutte 45.784
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.784


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.124 0 0 0 0 0 0 280 200 261 168 140 75
2020/20211.391 91 84 144 104 143 82 85 124 98 123 112 201
2021/20221.904 75 142 65 93 295 299 72 95 113 59 113 483
2022/20232.278 249 280 131 187 263 307 25 156 519 16 123 22
2023/20241.776 179 171 216 125 293 324 58 63 37 72 51 187
2024/20252.022 61 214 78 282 570 620 197 0 0 0 0 0
Totale 15.314